Literature DB >> 30471647

European Breast Cancer Council manifesto 2018: Genetic risk prediction testing in breast cancer.

Emiel Rutgers1, Judith Balmana2, Marc Beishon3, Karen Benn4, D Gareth Evans5, Robert Mansel6, Paul Pharoah7, Victoria Perry Skinner8, Dominique Stoppa-Lyonnet9, Luzia Travado10, Lynda Wyld11.   

Abstract

European Breast Cancer Council manifesto and supporting article on genetic risk prediction testing in breast cancer, presented at the 11th European Breast Cancer Conference in Barcelona, Spain.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  BRCA1/BRCA2; Breast cancer; Direct-to-consumer tests; Genetic counselling; Genetic testing; Regulation

Mesh：

Substances：

Year:  2018        PMID： 30471647     DOI： 10.1016/j.ejca.2018.09.019

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


  3 in total

1.  Implementation of interventions targeting the uptake of genetic testing services for breast cancer risk: protocol for a systematic review.

Authors:  Subash Thapa; Anja Leppin; Rikke Kristensen; Mette Just Bonde; Arja R Aro
Journal:  BMJ Open       Date:  2020-06-28       Impact factor: 2.692

2.  When to break the news and whose responsibility is it? A cross-sectional qualitative study of health professionals' views regarding disclosure of BRCA genetic cancer risk.

Authors:  Alison Luk Young; Phyllis N Butow; Katherine M Tucker; Claire E Wakefield; Emma Healey; Rachel Williams
Journal:  BMJ Open       Date:  2020-02-25       Impact factor: 2.692

3.  The requirements of a specialist breast centre.

Authors:  Laura Biganzoli; Fatima Cardoso; Marc Beishon; David Cameron; Luigi Cataliotti; Charlotte E Coles; Roberto C Delgado Bolton; Maria Die Trill; Sema Erdem; Maria Fjell; Romain Geiss; Mathijs Goossens; Christiane Kuhl; Lorenza Marotti; Peter Naredi; Simon Oberst; Jean Palussière; Antonio Ponti; Marco Rosselli Del Turco; Isabel T Rubio; Anna Sapino; Elzbieta Senkus-Konefka; Marko Skelin; Berta Sousa; Tiina Saarto; Alberto Costa; Philip Poortmans
Journal:  Breast       Date:  2020-02-26       Impact factor: 4.380
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.